Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

Apr 14, 2021

SELL
$16.71 - $19.9 $10,811 - $12,875
-647 Closed
0 $0
Q4 2020

Jan 14, 2021

SELL
$15.39 - $18.97 $4,062 - $5,008
-264 Reduced 28.98%
647 $12,000
Q3 2020

Oct 15, 2020

SELL
$17.1 - $19.19 $2,787 - $3,127
-163 Reduced 15.18%
911 $16,000
Q2 2020

Jul 30, 2020

BUY
$14.59 - $19.5 $2,378 - $3,178
163 Added 17.89%
1,074 $19,000
Q1 2019

Apr 08, 2019

BUY
$16.7 - $21.52 $15,213 - $19,604
911 New
911 $19,000

Others Institutions Holding TAK

About TAKEDA PHARMACEUTICAL CO LTD


  • Ticker TAK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 3,109,050,112
  • Market Cap $41.5B
  • Description
  • Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...
More about TAK
Track This Portfolio

Track Loring Wolcott & Coolidge Fiduciary Advisors LLP Portfolio

Follow Loring Wolcott & Coolidge Fiduciary Advisors LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Loring Wolcott & Coolidge Fiduciary Advisors LLP, based on Form 13F filings with the SEC.

News

Stay updated on Loring Wolcott & Coolidge Fiduciary Advisors LLP with notifications on news.